Dilemma of COVID-19, aging and cardiovascular disease

(JAMA Network) Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news